References
- Heemels M T, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Anna Rev Biochem. 1995; 64: 463–91
- Rock K L, Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu Rev Immunol. 1999; 17: 739–79
- Fruh K, Gruhler A, Krishna R M, Schoenhals G.J. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway [In Process Citation]. Immunol Rev. 1999; 168: 157–66
- Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol. 1989; 7: 601–24
- Ploegh H L. Viral strategies of immune evasion. Science 1998; 280: 248–53
- Ruiz-Cabello F, Garrido F. HLA and cancer: from research to clinical impact. Immunol Today 1998; 19: 539–42
- Jones T R, Hanson L K, Sun L, Slater J S, Stenberg R M, Campbell A.E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol. 1995; 69: 4830–41
- Wiertz E J, Jones T R, Sun L, Bogyo M, Geuze H J, Ploegh H.L. The human cytomegalovirus US 11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996; 84: 769–79
- Wiertz E J, Tortorella D, Bogyo M, Yu J, Mothes W, Jones T R, Rapoport T A, Ploegh H.L. Sec 61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction [see comments]. Nature 1996; 384: 432–8
- Tortorella D, Story C M, Huppa J B, Wiertz E J, Jones T R, Bacik I, Bennink J R, Yewdell J W, Ploegh H.L. Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential [published erratum appears in J Cell Biol 1999 May 3;145(3):following 642]. J Cell Biol. 1998; 142: 365–76
- Plemper R K, Wolf D.H. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem Sci. 1999; 24: 266–70
- Schusl D J, Tortorella D, Seebach J, Phan C, Ploegh H.L. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med. 1998; 188: 497–503
- Machold R P, Wiertz E J, Jones T R, Ploegh H.L. The HCMV gene products US 11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med. 1997; 185: 363–6
- Bankier A T, Beck S, Bohni R, Brown C M, Cerny R, Chee M S, Hutchison C.A.d., Kouzarides T, Martignetti J A, Preddie E, et al. The DNA sequence of the human cytomegalovirus genome. DNA Seq. 1991; 2: 1–12
- Story C M, Furmart M H, Ploegh H.L. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. Proc NatlAcad Sci USA 1999; 96: 8516–21
- Shamu C E, Story C M, Rapoport T A, Ploegh H.L. The Pathway of US11-dependent Degradation of MHC Class I Heavy Chains Involves a Ubiquitin-conjugated Intermediate. J Cell Biol. 1999; 147: 45–58